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RESUMEN
Se ha elaborado un modelo matemático para el ajuste
de la cinética de la reacción de asociación antígeno-anti-
cuerpo con el fin de distinguir los procesos con uno o
varios sitios de unión en las reacciones implicadas en la
determinación analítica de la Fosfatasa Alcalina Ósea
(sALP) por medio del análisis inmuno-radiomético (IRMA).
El modelo biexponencial dio el mejor ajuste y la más pre-
cisa estimación de los parámetros. El análisis de los datos
cinéticos explica satisfactoriamente la influencia de las
concentraciones de antígeno y anticuerpo admitiendo
que el enlace entre ellos tiene lugar a través de dos tipos
diferentes de sitios de unión. Esta conclusión no había
podido alcanzarse en base al análisis de los datos de
equilibrio.
Palabras clave: Cinética. IRMA. sALP. Sitios de unión.
Viscosidad. Fuerza iónica.
SUMMARY
A mathematical model was chosen to fit the antigen-anti-
body association kinetics whith a view to distinguishing
processes with either one o several binding sites in the
reactions involved in the analytical determination of
Skeletal Alkaline Phosphatase (sALP) by means of radio-
metric immunoassay (IRMA). The biexponential model
gave the best fit and the most precise estimation of its
parameters. The analysis of the kinetic data conducted  
satisfactorily explains the influence of the antigen and
antibody concentrations, by admitting that the antigen-
antibody binding takes place through two different bind-
ing site types. This conclusion would have not been
reached on the basic of equilibrium data analysis.
Key words: Kinetics. IRMA. sALP. Binding sites. Viscos-
ity. Ionic strength.
RESUM
S’ha elaborat un model matemàtic per a l’ajustament de
la cinètica de la reacció d’associació antigen-anticòs per
tal de distingir els processos amb un o diversos llocs d’u-
nió  en les reaccions implicades en la determinació ana-
lítica de la Fosfatasa Alcalina Òssia (sALP) mitjançant
l’anàlisi inmuno-radiométic (IRMA). El model biexponen-
cial va donar el millor ajustament i la més precisa esti-
mació dels paràmetres. L’anàlisi de les dades cinètiques
explica satisfactòriament la influència de les concentra-
cions d’antigen i anticòs admetent que l’enllaç entre ells
té lloc a través de dos tipus diferents de llocs d’unió.
Aquesta conclusió no havia pogut aconseguir-se en base
a l’anàlisi de les dades d’equilibri.
Mots clau: Cinètica. IRMA. sALP. Llocs d’unió. Viscositat.
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SYMBOLS
P = Antibody bound to the bead; Q = Skeletal alkaline
phosphatase (sALP); M = 125I-labelled anti-skeletal alkaline
phosphatase tracer antibody; PQ = Immunocomplex made
of the antibody bound to the tube with the sALP; PQM =
Sandwich-type radioactive immunocomplex; [P], [Q], [M],
[PQ], [PM] = Mol / L concentrations; P0, M0, Q0 = Initial con-
centrations in arbitrary units; Z = cpm activity measured in
each tube after reaction; (Z = Zsp + Z0). A sub-index is added
in the tables indicating the experiment number; Zsp = Activity
specifically bound to the tube wall, directly proportional to
the radioactive immunocomplex concentration; Z0 = Value
of Z obtained at t = 0, corresponds to unspecific binding;
Z∞ = Value of Z obtained at t infinity; Ze = Value of Zsp at
equilibrium (Ze = Z∞ – Z0); t = Time, in minutes; v0 = Initial
rate k = Rate constant; K = Equilibrium constant, r =
Correlation coefficient; SS= addition of residual squares;
N= number of points; P= number of parameters.
1. INTRODUCTION
The Tandem-ROstase assay is a solid-phase, two-site
immunoradiometric assay. Samples containing sALP are
reacted with plastic beads (solid phase) coated with a mon-
oclonal antibody directed towards a site on a site on the
sALP molecule and, simultaneously, with a radio-labelled
monoclonal antibody directed against a different antigenic
site on the same sALP molecule. Following the formation
on the solid-phase/sALP/labelled antibody sandwich, the
beads are washed to remove any unbound labelled anti-
body. The radioactivity bound to the solid phase is mea-
sured in a gamma counter. The amount of radioactivity
measured is directly proportional to the concentration of
sALP present in the sample.
The Tandem-ROstase Inmunoradiometric assay is a suit-
able in vitro device for the quantitative measurement of
skeletal alkaline phosphatase (sALP), an indicator of
osteoblastic activity, in human serum. The device is intend-
ed to be used as an aid in the management of post-
menopausal osteoporosis and Paget’s disease.
Kinetics and equilibrium in antigen-antibody reactions are
determining factors in the sensitiveness and accuracy of
immunoanalytical techniques(1-3). In previous research(4-9),
different characteristics have been studied in relation with
the antigen-antibody reactions used in analytical tech-
niques that employ radioactivity as a measurable magni-
tude. 
Equilibrium data analysis is used to a great extent in deter-
mining the capacity of a substance to bind to one or sev-
eral receptor populations. Nonetheless, as pointed out by
Weber(10), detecting two binding sites through such an assay
requires the ligand to have very different affinity for the two
binding sites. 
In their analysis of a hypothetical two-receptor site mod-
el, Tomlinson and Hnatowich(11) argued that apparent com-
petitive inhibition can be produced in different ways
depending on the specificity of the sites and the interac-
tions between them. Ideally, the validation of such a mod-
el would include: a) an independent study of the binding
of the ligand and the inhibitor in each other’s absence, b)
saturation and displacement experiments in a ligand and
inhibitor concentration range as broad as possible, c) sta-
tistical fitting and analysis. 
From a kinetic point of view, Giraudi et al(12) characterised
the antibody population involved in the binding of testos-
terone to its anti-serum. To that end, the authors followed
up the reaction between titrium-labelled testosterone and
a rabbit serum with pH = 7.4, constant ionic strength, a
temperature range from 2 to 37ºC, and concentrations of
a similar order to those used in the radioimmunoassay. The
dissociation process was followed up as from the addition
of an excess of unlabelled testosterone. The results point
to the existence of two biding site types in the antibody.
Drawn from the kinetic data, equilibrium constants were
very similar for both binding site types and in line with those
obtained through Scatchard representation.
Voss and Mummert(13) revised relationships between anti-
metatype antibody reactivity and the ligand-induced con-
formational state of monoclonal antibodies on the fluo-
rescein hapten as a small molecule model system. One
characteristic result of the interaction of anti-metatype anti-
bodies with liganded antibodies is a significant delay in the
dissociation rate (k2) of the ligand bound within the pri-
mary immune complex. Incorporation of principles inher-
ent in the anti-metatype concept and their application to
assay development were summarized.
Our research is aimed at applying a previously described
kinetic model(7, 8) to the reaction between sALP and its spe-
cific antibodies. Such a model should be able to account
for the influence of the concentration of the reagents for
both the global reaction and its stages. 
The ultimate goal is to distinguish between single-site and
two-site binding models by analysing kinetic data, as pro-
posed by Motulsky and Mahan(14) and later by Karlsson and
Neil(15). These authors noticed that the distinction between
single-site binding and two-site binding models was in
many cases impossible through equilibrium analysis, while
at the same time it was indeed feasible on the basis of
kinetic experiments. The latter authors proposed a method
which was applied to the study of the binding of titriade
Noscapine (antitussive) to guinea pig brain homogenate
which can have a general application for single and dou-
ble site binding model receptor populations with ligand
excess. This would allow for the discrimination between
binding models and the study of binding parameters by
using kinetic data only.
2. MATERIAL AND METHODS
2.1.Reagents
Anti-Skeletal Alkaline Phosphatase Tracer Antibody:
Solution of mouse monoclonal IgG labelled with 125I in a
bovine/mouse/horse protein matrix.
Anti-Skeletal Alkaline Phosphatase Coated Beads: Mouse
monoclonal IgG coated on plastic beads in a buffer con-
taining 0.1% sodium azide as a preservative. 
Skeletal Alkaline Phosphatase standard solutions.
All the reagents used were included in the Tandem®‚-
Ostase®‚ immunoradiometric assay kit manufactured by
Hybritech.
2.2. Instruments
LKB Gammamaster Automatic Gamma Counter. Brookfield
DV–II digital viscosimeter. Brookfield Digital Viscometer
DV-II. Viscosity measurements were performed at 60 rpm
with a UL ADAPTER at room temperature. 
Beads washing systems.
2.3. Experimental Procedure
Reaction kinetics were studied by placing the reagents in
the plastic tubes and letting them react at different times
and at 48 hours, this being considered infinite time. Each
bead is washed to remove any unbound labelled antibody.
Any radioactivity present in the remaining bound labelled
antibody is then measured using a gamma counter.
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All experiments were conducted at 5ºC, since sALP changes
above 9ºC.
15 experiments were performed, arranged as follows:
Experiments 1-9
Study of the influence of sALP (Q) and tracer (M) concen-
trations upon the global reaction. P and 100 μl of Q and
100 μl of M from different concentrations were left to react.
Experiments 10-12
Study of the influence of the concentrations of the previ-
ously mentioned factors upon the first process stage,
i.e. the binding of Q to the antibody bound to the bead (P).
Q-coated beads were incubated at different times; later
on and once washed, M was added and left to react for
24 hours.
Experiments 13-15
Study of the influence of the same factors upon the sec-
ond process stage, namely the binding of M to the PQ
immunocomplex. Beads and Q were left to react for
24 hours, and once washed M was added and left to react
at different times.
2.4. Data Analysis
The Statistica programme (Copyright© StatSoft, Inc:, 1993)
was used with specific non-linear regression equations. As
the statistical criterion(16, 17) that allows a choice from dif-
ferent equations, SS and Corrected Akaike´s Information
Criterion (AICc) was used, expressed as
AICc = N · ln ( ) + 2P + 
where N is the number of points, SS the addition of resid-
ual squares, and P the number of parameters in the equa-
tion. The fitting with the lowest AICc must be chosen. In
order to distinguish equations from monoexponential
and biexponential models, AICc and ANOVA (F test) were
used.
2P(P + 1)
N – P – 1
SS
N
2.5. Determination Of Initial Rate
Z values obtained depending on time were fitted to the
equation in all cases:
Z = a + b · t + c · t2
Since Z was initially assumed to be proportional to the im-
munocomplex concentration, the following could be written:
Z = α · [PM] + Z0 = a + b · t + c · t
2
α = Proportionality constant
v = = α · = b + 2c · t
v0 = ( )t = 0 = α · ( )t = 0 = b
Based on the above, coefficient b could be identified to
the process initial rate, provided
the immunocomplex activity in cpm is accepted as a con-
centration measurement in arbitrary
units. Conversion into mol·l–1 would demand the knowledge
of constant α.
3. RESULTS AND DISCUSSION
Influence of M and Q concentration. Global reaction and
stages.
This is the global process:
P + Q + M → PQM It can be broken down as follows: 
k1 k2
P + Q ⇔ PQ (quick)    and    PQ + M  ⇔ PQM (slow)
k–1 k–2
The second stage is slower, as can be seen in Table II; the
initial rates of this stage are quite close to those in the glob-
al process at equal concentrations (Table I). 
The rate equation for this process is:
Z = · {l – exp(– (d ·M0 – e ·Q0 + f) · t)} + g (Eq. 01)
a · M0 · Q0










Z and v0 values as a function of time for various concentrations of M and Q (Global Reaction).
t(min)
0 15 60 120 180 300 ∞ v0
M0 = 100, Q0 = 100 165.6 549.9 1237.0 1565.0 1658.3 2872.4 7697.3 9.90
M0 = 80, Q0 = 100 376.5 906.5 1423.8 2132.6 2790.4 4120.3 11479.6 14.31
M0 = 60, Q0 = 100 409.6 1290.5 1958.8 3075.2 3450.1 6452.4 13334.0 15.50
M0 = 40, Q0 = 100 396.9 1690.7 2203.0 3914.0 5085.0 5960.6 14604.2 33.16
M0 = 20, Q0 = 100 668.0 1693.0 2366.6 4368.3 5561.4 7673.3 12962.9 31.56
M0 = 100, Q0 = 14,9 479.9 748.7 679.6 1339.7 1679.8 1494.0 3329.0 9.57
M0 = 100, Q0 = 31,3 706.7 1017.6 1122.3 2055.9 2184.9 2216.9 5032.5 13.09
M0 = 100, Q0 = 44,8 856.0 1147.0 1373.5 2246.6 2776.6 3200.6 7132.7 13.73
M0 = 100, Q0 = 60,3 499.1 1104.5 1515.2 2870.1 3379.0 4285.5 8959.0 21.08
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The detailed deduction and validation of this equation can
be seen in previous papers(7, 8). 
Which can be written as follows:
Z = · {l – exp[– t ·d1 · (M0 + e1 ·Q0 + f1)]} + g1 (Eq. 1)
(Mono-exponential equation)
And for two binding sites, we have:
Z = · {l – exp[– t ·d1’ · (M0 + e1’ ·Q0 + f1’)]} +
+ · {l – exp[– t ·k1’ · (M0 + m1’ ·Q0 + n1’)]} + p1’
If in this ecuation we make the aproximations Q0 <<< j1’ and
m1’ · Q0 <<< m1’, there results:
Z = · {l – exp[– t ·d2 · (M0 + e2 ·Q0 + f2)]} +
+ · {l – exp[– t · j2 · (M0 + k2)]} + m2 (Eq. 2)
(Bi-exponential equation)
The results obtained in the global reaction for different M
and Q concentrations were studied in experiments 1-9,
whose results and correlation equations are shown in Table I.
Globally, the values fit with the equation:
Z = · {l – exp[– t ·d1 · (M0 + e1 ·Q0 + f1)]} + g1 (Eq. 1)
Its parameters, coefficient of correlation (r), sum of squares
of residuals (ss) and AICc are:
a1 = 172618 b1 = 16.98 c1 = 1007 d1 = 0.223·10-4 e1 = 0.51
f1 = –37.70 g1 = 758 r = 0.994 ss = 8.15·106 AICc = 760.20
Or with:
Z = · {l – exp(– t ·d2 · (M0 + e2 ·Q0 + f2))} +
+ · {l – exp(– t · j2 · (M0 + k2))} + m2 (Eq. 2)
g2 · M0 · Q0
(M0 + h2)
a2 · M0 · Q0
(M0 + b2) · (Q0 + c2)
a1 · M0 · Q0
(M0 + b1) · (Q0 + c1)
g2 · M0 · Q0
(M0 + h2)
a2 · M0 · Q0
(M0 + b2) · (Q0 + c2)
g1’ · M0 · Q0
(M0 + h1’) · (Q0 + j1’)
a1’ · M0 · Q0
(M0 + b1’) · (Q0 + c1’)
a1 · M0 · Q0
(M0 + b1) · (Q0 + c1)
Its parameters, coefficient of correlation (r), sum of squares
of residuals (ss) and AICc are:
a2 = 19226 b2 = –16.39 c2 = 165 d2 = 0.1898·10
–4 e2 = 0.434 f2 = –76.7 g2 = 34.84
h2 = –19.97 j2 = 0.0915 m2 = 650 r = 0.996 ss = 5.53·10
6 AICc = 747.34
The results of the two stages in which the global reaction
can be divided were studied in experiments 10-15, whose
results are shown in Table II.
Comparison of Mono and Bi-Exponential Models
For the comparison of mono- and bi-exponential models,
AICc and ANOVA (F test) were used
(15, 16).
Calculations were completed with the online calculator
GraphPad Quickcals®.
Model 1 corresponds to the monoexponential model, and
model 2 corresponds to the biexponential one.
Note that the F test assumes Model 2 to be a simpler case
than Model 1.
Model 2 (biexponential) has a lower AICc than Model 1
(monoexponential) and is more likely to be the correct mod-
el for all cases. In the global reaction, Model 2 is 620.2
times more likely to be correct than Model 1. 
Since the P value is below the traditional significance lev-
el of 5% (p < 0.005), we can conclude that the data fit sig-
nificantly better to Model 2 (Biexponential) than to Model 1
(Monoexponential).
4. CONCLUSION
The analysis of the kinetic data satisfactorily explains the
influence of the antigen and antibody concentrations.
The bi-exponential model fits better than the mono-expo-
nential one as far as the obtained results are concerned,
this justifying the influence of Q and M concentrations.
Therefore, the conclusion could be drawn that experi-
mental results are better explained by admitting that
two different processes occur –corresponding to the two-
site binding reactions– in the interaction between
sALP and its antibody immobilised on a spherical sur-
face.
TABLE II
Z and v0 values as a function of time for various concentrations of M and Q (Stages).
t(min)
0 15 60 120 180 300 ∞ v0
Stage 1
M0 = 100, Q0 = 100 902.0 1631.0 1958.8 2455.8 3494.0 3673.6 3983.8 16.24
M0 = 40, Q0 = 100 601.9 783.1 1265.3 2004.0 2549.5 2335.2 2710.6 16.99
M0 = 100, Q0 = 44,8 947.9 943.3 1272.9 1409.4 1759.4 2038.5 2797.5 5.37
Stage 2
M0 = 100, Q0 = 100 735.5 1625.3 1592.8 1831.1 2640.5 4133.4 6094.5 5.69
M0 = 40, Q0 = 100 414.5 790.9 1178.5 1500.0 1459.6 1599.9 4091.2 9.76
M0 = 100, Q0 = 44,8 603.5 984.0 926.8 1156.4 1948.4 2034.5 2637.5 5.70
Stage 2 is the slowest and so limits the process rate.
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